|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||251.90 - 251.90|
|52-week range||251.90 - 251.90|
|Beta (5Y monthly)||0.75|
|PE ratio (TTM)||N/A|
|Earnings date||02 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
IRVING, Texas, January 18, 2022--McKesson Corporation (NYSE: MCK) announced today that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022. McKesson expects that the board will appoint Hinton to the Compliance Committee and Governance Committee and Wilson-Thompson to the Compensation Committee and Governance Committee. With the election of Hinton and Wilson-Thompson, McKesson’s board of directors increases from 9 to 11 members.
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Investors are optimistic about Omnicell (OMCL) on strength in medication management and adherence automation solutions.